<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>16</volume><submitter>Wu X</submitter><pubmed_abstract>&lt;h4>Background&lt;/h4>Acute Respiratory Distress Syndrome (ARDS) is a critical condition with high ICU mortality. Despite treatments such as mechanical ventilation, outcomes remain poor, with in-hospital mortality reaching 40% and various complications negatively affecting patient prognosis. Chinese Herbal Medicines (CHM) offers a promising, safe, and reliable alternative therapy. When combined with Western symptomatic treatments, CHM can produce synergistic effects, enhancing the overall intervention and improving patient outcomes.&lt;h4>Objective&lt;/h4>This study aims to evaluate the efficacy of four CHMs - Xuanbai Chengqi Decoction (XBCQD), Dachengqi Decoction (DCQD), Liangge Powder (LGP), and Fusu Agent (FSA) - in managing ARDS. Using a network meta-analysis (NMA), the study ranks these formul</pubmed_abstract><journal>Frontiers in pharmacology</journal><pagination>1671930</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12678923</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Efficacy comparison of four different Chinese herbal mediciness in intervening acute respiratory distress syndrome: a bayesian network meta-analysis.</pubmed_title><pmcid>PMC12678923</pmcid><pubmed_authors>Liu Z</pubmed_authors><pubmed_authors>Wang F</pubmed_authors><pubmed_authors>Luo Y</pubmed_authors><pubmed_authors>Feng S</pubmed_authors><pubmed_authors>Wu X</pubmed_authors><pubmed_authors>Dai X</pubmed_authors></additional><is_claimable>false</is_claimable><name>Efficacy comparison of four different Chinese herbal mediciness in intervening acute respiratory distress syndrome: a bayesian network meta-analysis.</name><description>&lt;h4>Background&lt;/h4>Acute Respiratory Distress Syndrome (ARDS) is a critical condition with high ICU mortality. Despite treatments such as mechanical ventilation, outcomes remain poor, with in-hospital mortality reaching 40% and various complications negatively affecting patient prognosis. Chinese Herbal Medicines (CHM) offers a promising, safe, and reliable alternative therapy. When combined with Western symptomatic treatments, CHM can produce synergistic effects, enhancing the overall intervention and improving patient outcomes.&lt;h4>Objective&lt;/h4>This study aims to evaluate the efficacy of four CHMs - Xuanbai Chengqi Decoction (XBCQD), Dachengqi Decoction (DCQD), Liangge Powder (LGP), and Fusu Agent (FSA) - in managing ARDS. Using a network meta-analysis (NMA), the study ranks these formul</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025</publication><modification>2026-06-05T23:28:04.555Z</modification><creation>2026-05-23T03:13:21.083Z</creation></dates><accession>S-EPMC12678923</accession><cross_references><pubmed>41357897</pubmed><doi>10.3389/fphar.2025.1671930</doi></cross_references></HashMap>